Identification and characterization of a phenyl-thiazolyl-benzoic acid derivative as a novel RAR/RXR agonist

Por Koshiishi, Chie, Kanazawa, Takanori, Vangrevelinghe, Eric, Honda, Toshiyuki, Hatakeyama, Shinji
Publicado no Heliyon (2019)

An Activating Janus Kinase-3 Mutation Is Associated with Cytotoxic T Lymphocyte Antigen-4-Dependent Immune Dysregulation Syndrome

Por Sic, Heiko, Speletas, Matthaios, Cornacchione, Vanessa, Seidl, Maximillian, Beibel, Martin, Linghu, Bolan, Yang, Fan, Sevdali, Eirini, Germenis, Anastasios E., Oakeley, Edward J., Vangrevelinghe, Eric, Sailer, Andreas W., Traggiai, Elisabetta, Gram, Hermann, Eibel, Hermann
Publicado no Front Immunol (2017)

A Small-Molecule Dengue Virus Entry Inhibitor

Por Wang, Qing-Yin, Patel, Sejal J., Vangrevelinghe, Eric, Xu, Hao Ying, Rao, Ranga, Jaber, Deana, Schul, Wouter, Gu, Feng, Heudi, Olivier, Ma, Ngai Ling, Poh, Mee Kian, Phong, Wai Yee, Keller, Thomas H., Jacoby, Edgar, Vasudevan, Subhash G.
Publicado em 2009

Modulation of activation-loop phosphorylation by JAK inhibitors is binding mode dependent

Por Andraos, Rita, Qian, Zhiyan, Bonenfant, Débora, Rubert, Joëlle, Vangrevelinghe, Eric, Scheufler, Clemens, Marque, Fanny, Régnier, Catherine H., De Pover, Alain, Ryckelynck, Hugues, Bhagwat, Neha, Koppikar, Priya, Goel, Aviva, Wyder, Lorenza, Tavares, Gisele, Baffert, Fabienne, Pissot-Soldermann, Carole, Manley, Paul W., Gaul, Christoph, Voshol, Hans, Levine, Ross L., Sellers, William R., Hofmann, Francesco, Radimerski, Thomas
Publicado no Cancer Discov (2012)

Genetic resistance to JAK2 enzymatic inhibitors is overcome by HSP90 inhibition

Por Weigert, Oliver, Lane, Andrew A., Bird, Liat, Kopp, Nadja, Chapuy, Bjoern, van Bodegom, Diederik, Toms, Angela V., Marubayashi, Sachie, Christie, Amanda L., McKeown, Michael, Paranal, Ronald M., Bradner, James E., Yoda, Akinori, Gaul, Christoph, Vangrevelinghe, Eric, Romanet, Vincent, Murakami, Masato, Tiedt, Ralph, Ebel, Nicolas, Evrot, Emeline, De Pover, Alain, Régnier, Catherine H., Erdmann, Dirk, Hofmann, Francesco, Eck, Michael J., Sallan, Stephen E., Levine, Ross L., Kung, Andrew L., Baffert, Fabienne, Radimerski, Thomas, Weinstock, David M.
Publicado em 2012

Activity of the type II JAK2 inhibitor CHZ868 in B-cell acute lymphoblastic leukemia

Por Wu, Shuo-Chieh, Li, Loretta S., Kopp, Nadja, Montero, Joan, Chapuy, Bjoern, Yoda, Akinori, Christie, Amanda L., Liu, Huiyun, Christodoulou, Alexandra, van Bodegom, Diederik, van der Zwet, Jordy, Layer, Jacob V., Tivey, Trevor, Lane, Andrew A., Ryan, Jeremy A., Ng, Samuel Y., DeAngelo, Daniel J., Stone, Richard M., Steensma, David, Wadleigh, Martha, Harris, Marian, Mandon, Emeline, Ebel, Nicolas, Andraos, Rita, Romanet, Vincent, Dölemeyer, Arno, Sterker, Dario, Zender, Michael, Rodig, Scott J., Murakami, Masato, Hofmann, Francesco, Kuo, Frank, Eck, Michael J., Silverman, Lewis B., Sallan, Stephen E., Letai, Anthony, Baffert, Fabienne, Vangrevelinghe, Eric, Radimerski, Thomas, Gaul, Christoph, Weinstock, David M.
Publicado no Cancer Cell (2015)